The state of the prion

Nature Reviews Microbiology

Volumn 2, Issue 11, 2004, Pages 861-871

  Weissmann, Charles ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b The Scripps Research Institute Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

BRAIN SPONGIOSIS; NONHUMAN; PRION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STRUCTURE; REVIEW; STRAIN DIFFERENCE; VIRUS PATHOGENESIS; VIRUS STRAIN;

ANIMALS; HUMANS; PRION DISEASES; PRIONS; PROTEIN CONFORMATION; PRPC PROTEINS; PRPSC PROTEINS;

EID: 9444267651     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1025     Document Type: Review

References (124)

1. Prusiner, S. B. Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144 (1982).
2. Oesch, B. et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell 40, 735-746 (1985).
3. Chesebro, B. et al. Identification of scrapie prion protein-specific messenger RNA in scrapie-infected and uninfected brain. Nature 315, 331-333 (1985).
4. Basler, K. et al. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46, 417-428 (1986).
5. Stahl, N. et al. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32, 1991-2002 (1993).
6. Prusiner, S. B. Prions causing degenerative neurological diseases. Annu. Rev. Med. 38, 381-398 (1987).
7. Hsiao, K. et al. Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature 338, 342-345 (1989).
8. Prusiner, S. B. et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63, 673-686 (1990).
9. Büeler, H. et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577-582 (1992).
10. Büeler, H. et al. Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347 (1993).
11. Wickner, R. B. et al. Yeast prions act as genes composed of self-propagating protein amyloids. Adv. Protein Chem. 57, 313-334 (2001).
12. Riesner, D. et al. Prions and nucleic acids: search for 'residual' nucleic acids and screening for mutations in the PrP gene. Dev. Biol. Stand. 80, 173-181 (1993).
13. Chesebro, B. Prion protein and the transmissible spongiform encephalopathy diseases. Neuron 24, 503-606 (1999).
14. Manuelidis, L. Transmissible encephalopathies: speculations and realities. Viral Immunol. 16, 123-139 (2003).
15. Kimberlin, R. H. Scrapie agent: prions or virinos? Nature 297, 107-108 (1982).
16. Griffith, J. S. Self-replication and scrapie. Nature 215, 1043-1044 (1967).
17. Prusiner, S. B. Molecular biology of prion diseases. Science 252, 1515-1522 (1991).
18. Weissmann, C. A 'unified theory' of prion propagation. Nature 352, 679-683 (1991).
19. Meyer, R. K. et al. Separation and properties of cellular and scrapie prion proteins. Proc. Natl Acad. Sci. USA 83, 2310-2314 (1986).
20. Sc molecules with different conformations. Nature Med. 4, 1157-1165 (1998).
21. Peretz, D. et al. Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci. 10, 854-863 (2001).
22. Neary, K., Caughey, B., Ernst, D., Race, R. E. & Chesebro, B. Protease sensitivity and nuclease resistance of the scrapie agent propagated in vitro in neuroblastoma cells. J. Virol. 65 1031-1034 (1991).
23. McKinley, M. P., Bolton, D. C. & Prusiner, S. B. A protease-resistant protein is a structural component of the scrapie prion. Cell 35, 57-62 (1983).
24. Kuczius, T. & Groschup, M. H. Differences in proteinase K resistance and neuronal deposition of abnormal prion proteins characterize bovine spongiform encephalopathy (BSE) and scrapie strains. Mol. Med. 5, 406-418 (1999).
25. Harris, D. A. et al. A transgenic model of a familial prion disease. Arch. Virol. Suppl. 103-112 (2000).
26. Post, K. et al. Rapid acquisition of β-sheet structure in the prion protein prior to multimer formation. Biol. Chem. 379, 1307-1317 (1998).
27. Appel, T. R., Dumpitak, C., Matthiesen, U. & Riesner, D. Prion rods contain an inert polysaccharide scaffold. Biol. Chem. 380, 1295-1306 (1999).
28. Bolton, D. C., Rudelli, R. D., Currie, J. R. & Bendheim, P. E. Copurification of Sp33-37 and scrapie agent from hamster brain prior to detectable histopathology and clinical disease. J. Gen. Virol. 72, 2905-2913 (1991).
29. Weissmann, C. Spongiform encephalopathies. The prion's progress. Nature 349, 569-571 (1991).
30. Manson, J. C. et al. A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J. 18, 6855-6864 (1999).
31. Lasmezas, C. I. et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275, 402-405 (1997).
32. Collinge, J. et al. Transmission of fatal familial insomnia to laboratory animals. Lancet 346, 569-570 (1995).
33. Manuelidis, L., Sklaviadis, T. & Manuelidis, E. E. Evidence suggesting that PrP is not the infectious agent in Creutzfeldt-Jakob disease. EMBO J. 6, 341-347 (1987).
34. Tzaban, S. et al. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 41 12868-12875 (2002).
35. Sc conformers induced by a synthetic peptide and several prion strains. J. Virol. 78 2088-2099 (2004).
36. Prusiner, S. B. & Scott, M. R. Genetics of prions. Annu. Rev. Genet. 31, 139-175 (1997).
37. Liemann, S. & Glockshuber, R. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 38, 3258-3267 (1999).
38. Jarrett, J. T. & Lansbury, P. J. Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058 (1993).
39. Orgel, L. E. Prion replication and secondary nucleation. Chem. Biol. 3, 413-414 (1996).
40. Vanik, D. L., Surewicz, K. A. & Surewicz, W. K. Molecular basis of barriers for interspecies transmissibility of mammalian prions. Mol. Cell 14, 139-145 (2004).
41. Chernoff, Y. O., Lindquist, S. L., Ono, B., Inge-Vechtomov, S. G. & Liebman, S. W. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 268 880-884 (1995).
42. Wickner, R. B. et al. Prions of yeast as heritable amyloidoses. J. Struct. Biol. 130, 310-322 (2000).
43. Enari, M., Flechsig, E. & Weissmann, C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl Acad. Sci. USA 98, 9295-9299 (2001).
44. Montrasio, F. et al. B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice. Proc. Natl Acad. Sci. USA 98, 4034-4037 (2001).
45. Telling, G. C. et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83, 79-90 (1995 ).
46. Peretz, D. et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412, 739-743 (2001).
47. Priola, S. A. & Chesebro, B. A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells. J. Virol. 69, 7754-7758 (1995).
48. Hunter, N. in Prion Diseases (eds Baker, H. F. & Ridley, R. M.) 211-221 (Humana Press, New Jersey, 1996).
49. Perrier, V. et al. Dominant-negative inhibition of prion replication in transgenic mice. Proc. Natl Acad. Sci. USA 23, 23 (2002).
50. Windl, O. et al. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum. Genet. 98 259-264 (1996).
51. Collinge, J. & Rossor, M. A new variant of prion disease. Lancet 347, 916-917 (1996).
52. Peden, A. H., Head, M. W., Ritchie, D. L., Bell, J. E. & Ironside, J. W. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364, 527-529 (2004).
53. Race, R. E., Fadness, L. H. & Chesebro, B. Characterization of scrapie infection in mouse neuroblastoma cells. J. Gen. Virol. 68, 1391-1399 (1987).
54. Rubenstein, R., Carp, R. I. & Callahan, S. M. In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells. J. Gen. Virol. 66, 2191-2198 (1984).
55. Schatzl, H. M. et al. A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J. Virol. 71, 8821-8831 (1997).
56. Vorberg, I., Raines, A., Story, B. & Priola, S. A. Susceptibility of common fibroblast cell lines to transmissible spongiform encephalopathy agents. J. Infect. Dis. 189, 431-439 (2004).
57. Vilette, D. et al. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc. Natl Acad. Sci. USA 98, 4055-4059 (2001).
58. Bosque, P. J. & Prusiner, S. B. Cultured cell sublines highly susceptible to prion infection. J. Virol. 74, 4377-4386 (2000).
59. Kloehn, P.-C., Stoltze, I., Flechsig, E., Enari, M. & Weissmann, C. A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc. Natl Acad. Sci. USA 100 11666-11671 (2003).
60. Nishida, N. et al. Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J. Virol. 74, 320-325 (2000).
61. Fischer, M. et al. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15, 1255-1264 (1996).
62. Kaneko, K. et al. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc. Natl Acad. Sci. USA 94, 10069-10074 (1997).
63. Kuczius, T., Haist, I. & Groschup, M. H. Molecular analysis of bovine spongiform encephalopathy and scrapie strain variation. J. Infect. Dis. 178, 693-699 (1998).
64. Kocisko, D. A. et al. Cell-free formation of protease-resistant prion protein. Nature 370, 471-474 (1994).
65. Saborio, G. P., Permanne, B. & Soto, C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810-813 (2001).
66. Deleault, N. R., Lucassen, R. W. & Supattapone, S. RNA molecules stimulate prion protein conversion. Nature 425, 717-720 (2003).
67. Legname, G. et al. Synthetic mammalian prions. Science 305, 673-376 (2004).
68. Bruce, M. E., Fraser, H., McBride, P. A., Scott, J. R. & Dickinson, A. G. in Prion Diseases of Humans and Animals (eds Prusiner, S. B., Collinge, J., Powell, J. & Anderton, B.) 497-508 (Ellis Horwood, New York, London, 1992).
69. Bessen, R. A. & Marsh, R. F. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J. Virol. 66, 2096-2101 (1992).
70. Telling, G. C. et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274, 2079-2082 (1996).
71. Collinge, J., Sidle, K. C., Meads, J., Ironside, J. & Hill, A. F. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383, 685-690 (1996).
72. Safar, J. G. et al. Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoessays and transgenic mice. Nature Biotechnol. 20, 1147-1150 (2002).
73. Bellon, A. et al. Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity. J. Gen. Virol. 84, 1921-1925 (2003).
74. Caughey, B. et al. Methods for studying prion protein (PrP) metabolism and the formation of protease-resistant PrP in cell culture and cell-free systems. An update. Mol. Biotechnol. 13 45-55 (1999).
75. Tanaka, M., Chien, P., Naber, N., Cooke, R. & Weissman, J. S. Conformational variations in an infectious protein determine prion strain differences. Nature 428, 323-8. (2004).
76. King, C. Y. & Diaz-Avalos, R. Protein-only transmission of three yeast prion strains. Nature 428, 319-323 (2004).
77. Kimberlin, R. H., Cole, S. & Walker, C. A. Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. J. Gen. Virol. 68, 1875-1881 (1987).
78. DeArmond, S. J. et al. Selective neuronal targeting in prion disease. Neuron 19, 1337-1348 (1997).
79. Miller, M. W., Williams, E. S., Hobbs, N. T. & Wolfe, L. L. Environmental sources of prion transmission in mule deer. Emerg. Infect. Dis. 10, 1003-1006 (2004).
80. Pattison, I. H. in NINDB Monograph No. 2, Slow, Latent and Temperate Virus Infections (eds Gajdusek, D. C., Gibbs, C. J. & Alpers, M.) 249-257 (1965).
81. Hill, A. F. et al. Species-barrier-independent prion replication in apparently resistant species. Proc. Natl Acad. Sci. USA 97, 10248-10253 (2000).
82. Race, R., Raines, A., Raymond, G. J., Caughey, B. & Chesebro, B. Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans. J. Virol. 75, 10106-10112 (2001).
83. Asante, E. A. et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J. 21, 6358-6366 (2002).
84. Scott, M. R. et al. Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice. Proc. Natl Acad. Sci. USA 94, 14279-14284 (1997).
85. Lloyd, S. E. et al. Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc. Natl Acad. Sci. USA 98, 6279-6283 (2001).
86. Stephenson, D. A. et al. Quantitative trait loci affecting prion incubation time in mice. Genomics 69, 47-53 (2000).
87. Moreno, C. R., Lantier, F., Lantier, I., Sarradin, P. & Elsen, J. M. Detection of new quantitative trait loci for susceptibility to transmissible spongiform encephalopathies in mice. Genetics 165, 2085-2091 (2003).
88. Manolakou, K. et al. Genetic and environmental factors modify bovine spongiform encephalopathy incubation period in mice. Proc. Natl Acad. Sci. USA 98, 7402-7407 (2001).
89. Wickner, R. B. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264, 566-569 (1994).
90. Wickner, R. B., Edskes, H. K., Roberts, B. T., Pierce, M. & Baxa, U. Prions of yeast as epigenetic phenomena: high protein 'copy number' inducing protein 'silencing'. Adv. Genet. 46, 485-525 (2002).
91. Glover, J. R. et al. Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae. Cell 89, 811-819 (1997).
92. Blättler, T. et al. PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 389, 69-73 (1997).
93. c) is required for scrapie spread within the central nervous system. Proc. Natl Acad. Sci. USA 93, 13148-13151 (1996).
94. Sc from the gut. J. Gen. Virol. 83, 267-271 (2002).
95. Klein, M. A. et al. PrP expression in B lymphocytes is not required for prion neuroinvasion. Nature Med. 4, 1429-1433 (1998).
96. Kitamoto, T., Muramoto, T., Mohri, S., Dohura, K. & Tateishi, J. Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease. J. Virol. 65, 6292-6295 (1991).
97. Mackay, F. & Browning, J. L. Turning off follicular dendritic cells. Nature 395, 26-27 (1998).
98. Montrasio, F. et al. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288, 1257-1259 (2000).
99. Mabbott, N. A., Mackay, F., Minns, F. & Bruce, M. E. Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nature Med. 6, 719-720 (2000).
100. Mabbott, N. A., Young, J., McConnell, I. & Bruce, M. E. Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility. J. Virol. 77, 6845-6854 (2003).
101. Glatzel, M., Heppner, F. L., Albers, K. M. & Aguzzi, A. Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron 31, 25-34 (2001).
102. Race, R., Oldstone, M. & Chesebro, B. Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen. J. Virol. 74, 828-833 (2000).
103. Mallucci, G. R. et al. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J. 21, 202-210 (2002).
104. Sc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol. Med. 1, 19-30 (1994).
105. Brandner, S. et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339-343 (1996).
106. Mallucci, G. et al. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302 871-874 (2003).
107. Ma, J., Wollmann, R. & Lindquist, S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science, 1781-1785 (2002).
108. Sc-like conformation in the cytosol. Science 298, 1785-1788 (2002).
109. Drisaldi, B. et al. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J. Biol. Chem. 278, 21732-21743 (2003).
110. Heller, U., Winklhofer, K. F., Heske, J., Reintjes, A. & Tatzelt, J. Post-translational import of the prion protein into the endoplasmic reticulum interferes with cell viability: a critical role for the putative transmembrane domain. J. Biol. Chem. 278, 36139-36147 (2003).
111. Roucou, X., Guo, Q., Zhang, Y., Goodyer, C. G. & LeBanc, A. C. Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons. J. Biol. Chem. 278, 40877-40881 (2003).
112. Hegde, R. S. et al. Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 402 822-826 (1999).
113. Hegde, R. S. et al. A transmembrane form of the prion protein in neurodegenerative disease. Science 279, 827-834 (1998).
114. Carrell, R. W. & Lomas, D. A. Conformational disease. Lancet 350, 134-138 (1997).
115. Lansbury, P. T. Jr. Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc. Natl Acad. Sci. USA 96, 3342-3324 (1999).
116. Flechsig, E., Manson, J. C., Barron, R., Aguzzi, A. & Weissmann, C. in Prion Biology and Diseases (ed. Prusiner, S. B.) 373-434 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 2004).
117. Tateishi, J., Kitamoto, T., Hoque, M. Z. & Furukawa, H. Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents. Neurology 46, 532-537 (1996).
118. Chiesa, R. et al. Molecular distinction between pathogenic and infectious properties of the prion protein. J. Virol. 77, 7611-7622 (2003).
119. Goldfarb, L. G. et al. Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the Pmp gene. Proc. Natl Acad. Sci. USA 88, 10926-10930 (1991).
120. Tateishi, J. & Kitamoto, T. Inherited prion diseases and transmission to rodents. Brain Pathol. 5, 53-59 (1995).
121. True, H. L. & Lindquist, S. L. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 407, 477-483 (2000).
122. Chiti, F. et al. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl Acad. Sci. USA 96, 3590-3594 (1999).
123. Weissmann, C. Molecular biology of prion diseases. Trends Cell Biol. 4, 10-14 (1994).
124. Weissmann, C., Enari, M., Klohn, P. C., Rossi, D. & Flechsig, E. Transmission of prions. Proc. Natl Acad. Sci. USA 14, 14 (2002).